SBF on the Move Again: From 'Victimville' to Low-Security Prison

JP Morgan reaffirmed its Overweight rating for Regeneron Pharmaceuticals and increased its price target to $1050 from $950, suggesting a 13.2% upside from the Oct 30 close of $927.89. Recent analyst price targets for the company range from $825 to $980.

JP Morgan kept Reddit at a Neutral rating but reduced its price target to $150 from $185, an 18.9% cut. This implies a 63.5% upside from the Oct 30 close of $91.73. Recent analyst price targets for Reddit range from $110 to $210.

Alaska Air Group plans to cut 200 non-contract jobs due to rising fuel costs and geopolitical challenges, potentially leading to a $700 million annual loss. This would be the airline's first adjusted pre-tax loss outside the pandemic since 2003, according to CEO Ben Minicucci.

The U.S. approved a $2.1B sale of 500 Patriot PAC-3 missiles and related equipment to Ukraine. Ukraine will fund the purchase with donations from Canada, Germany, Norway, and EU support. Lockheed Martin is the principal contractor. Ukraine reportedly needs more missiles for its Patriot air defense systems.

JP Morgan kept Republic Services at Neutral but raised its price target to $265 from $245, an 8.2% increase. The new target suggests an 8.6% upside from the Oct 30 close of $244.04. Recent analyst price targets for the company range from $219 to $277.

JP Morgan kept its Overweight rating on Merck & Co and increased its price target to $175 from $165, suggesting a 17% upside from the Oct 30 close. Recent analyst targets range from $140 to $180.